Rytelo: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 June 2024

21 June 2024

  • curprev 02:4602:46, 21 June 2024Kosar Doraghi talk contribs 10,735 bytes +10,735 Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:K.doraghi@yahoo.com] |genericName=Imetelstat |aOrAn=an |drugClass=oligonucleotide telomerase inhibitor |indicationType=treatment |indication=oligonucleotide telomerase inhibitor adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are..."